Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-18-027186
Filing Date
2018-05-10
Accepted
2018-05-10 17:02:32
Documents
43
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tv493103_10q.htm 10-Q 185587
2 EXHIBIT 31.1 tv493103_ex31-1.htm EX-31.1 11405
3 EXHIBIT 31.2 tv493103_ex31-2.htm EX-31.2 11438
4 EXHIBIT 32.1 tv493103_ex32-1.htm EX-32.1 4934
5 EXHIBIT 32.2 tv493103_ex32-2.htm EX-32.2 5256
  Complete submission text file 0001144204-18-027186.txt   1403678

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT enzn-20180331.xml EX-101.INS 192656
7 XBRL TAXONOMY EXTENSION SCHEMA enzn-20180331.xsd EX-101.SCH 22096
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE enzn-20180331_cal.xml EX-101.CAL 14027
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE enzn-20180331_def.xml EX-101.DEF 102657
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE enzn-20180331_lab.xml EX-101.LAB 134585
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE enzn-20180331_pre.xml EX-101.PRE 124213
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Filer) CIK: 0000727510 (see all company filings)

EIN.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36435 | Film No.: 18823848
SIC: 2836 Biological Products, (No Diagnostic Substances)